These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6483197)

  • 1. [The level of ammonia and its metabolites in the brain in experimental hepatic encephalopathy induced by long-term administration of thioacetamine and during recovery].
    Hilgier W; Albrecht J
    Neuropatol Pol; 1984; 22(2):179-84. PubMed ID: 6483197
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thioacetamide-induced hepatic encephalopathy in the rat. III Ammonia level and its metabolic substrates in the brain].
    Hilgier W
    Neuropatol Pol; 1983; 21(4):511-8. PubMed ID: 6142431
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ammonia content and glutamine synthetase and glutaminase activity in the brain in experimental hepatic coma].
    Hilgier W
    Neuropatol Pol; 1981; 19(3):351-8. PubMed ID: 6119654
    [No Abstract]   [Full Text] [Related]  

  • 4. On mechanisms in hyperammonemic coma--with particular reference to hepatic encephalopathy.
    Hindfelt B
    Ann N Y Acad Sci; 1975 Apr; 252():116-23. PubMed ID: 238449
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral amino acid metabolism in hepatic coma.
    Berl S
    Exp Biol Med; 1971; 4():71-84. PubMed ID: 5162461
    [No Abstract]   [Full Text] [Related]  

  • 6. Taurine release from brain slices in thioacetamide-induced hepatic encephalopathy in rats.
    Wysmyk U; Oja SS; Saransaari P
    Mol Chem Neuropathol; 1991 Feb; 14(1):25-34. PubMed ID: 1910355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-ketoglutaramate, a neurotoxic agent in hepatic coma.
    Vergara F; Duffy TE; Plum F
    Trans Assoc Am Physicians; 1973; 86():255-63. PubMed ID: 4788800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic disorders in hepatic encephalopathy].
    Albrecht J
    Neuropatol Pol; 1984; 22(4):499-508. PubMed ID: 6152488
    [No Abstract]   [Full Text] [Related]  

  • 9. Severity of hyperammonemic encephalopathy correlates with brain ammonia level and saturation of glutamine synthetase in vivo.
    Kanamori K; Ross BD; Chung JC; Kuo EL
    J Neurochem; 1996 Oct; 67(4):1584-94. PubMed ID: 8858943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha-ketoglutarate and glutamate content of the rat brain in experimental hepatic coma].
    Hilgier W
    Neuropatol Pol; 1980; 18(1):121-6. PubMed ID: 7383346
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain ion and amino acid contents during edema development in hepatic encephalopathy.
    Hilgier W; Olson JE
    J Neurochem; 1994 Jan; 62(1):197-204. PubMed ID: 8263520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-ketoglutaramate in hepatic encephalopathy.
    Duffy TE; Vergara F; Plum F
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():39-52. PubMed ID: 4438817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gamma-aminobutyric acid (GABA) metabolism in the rat brain in experimental hepatic encephalopathy].
    Wysmyk-Cybula U
    Neuropatol Pol; 1983; 21(4):519-27. PubMed ID: 6669231
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-ketoglutarmate, glutamate antagonism and GABA depletion--clues to the pathogenesis of hepatic encephalopathy?
    Kardel T; Gips CH
    Neth J Med; 1974; 17(2):37-41. PubMed ID: 4839372
    [No Abstract]   [Full Text] [Related]  

  • 15. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.
    Cordoba J; Gottstein J; Blei AT
    Hepatology; 1996 Oct; 24(4):919-23. PubMed ID: 8855198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of hepatic encephalopathy--with special reference to the role of ammonia.
    Walker CO; Schenker S
    Am J Clin Nutr; 1970 May; 23(5):619-32. PubMed ID: 5444996
    [No Abstract]   [Full Text] [Related]  

  • 17. The brain octopamine and phenylethanolamine content in rats in thioacetamide-induced hepatogenic encephalopathy.
    Hilgier W; Zitting A; Albrecht J
    Acta Neurol Scand; 1985 Mar; 71(3):195-8. PubMed ID: 3922198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptosomal uptake of alpha-ketoglutarate and glutamine in thioacetamide-induced hepatic encephalopathy in rats.
    Albrecht J; Waskiewicz J; Dolinska M; Rafalowska U
    Metab Brain Dis; 1997 Dec; 12(4):281-6. PubMed ID: 9475501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy.
    Fraser CL; Arieff AI
    N Engl J Med; 1985 Oct; 313(14):865-73. PubMed ID: 2993889
    [No Abstract]   [Full Text] [Related]  

  • 20. α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.
    Cooper AJ; Kuhara T
    Metab Brain Dis; 2014 Dec; 29(4):991-1006. PubMed ID: 24234505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.